CA2538009A1 - Combinaison d'amides de l'acide phenylcarboxylique avec des bloquants des recepteurs beta-adrenergiques et leur utilisation dans le traitement d'arythmies atriales - Google Patents

Combinaison d'amides de l'acide phenylcarboxylique avec des bloquants des recepteurs beta-adrenergiques et leur utilisation dans le traitement d'arythmies atriales Download PDF

Info

Publication number
CA2538009A1
CA2538009A1 CA002538009A CA2538009A CA2538009A1 CA 2538009 A1 CA2538009 A1 CA 2538009A1 CA 002538009 A CA002538009 A CA 002538009A CA 2538009 A CA2538009 A CA 2538009A CA 2538009 A1 CA2538009 A1 CA 2538009A1
Authority
CA
Canada
Prior art keywords
beta
blockers
carbon atoms
compounds
atenolol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002538009A
Other languages
English (en)
Inventor
Klaus Wirth
Joachim Brendel
Heinz Goegelein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34202398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2538009(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Publication of CA2538009A1 publication Critical patent/CA2538009A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002538009A 2003-09-08 2004-09-03 Combinaison d'amides de l'acide phenylcarboxylique avec des bloquants des recepteurs beta-adrenergiques et leur utilisation dans le traitement d'arythmies atriales Abandoned CA2538009A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10341233A DE10341233A1 (de) 2003-09-08 2003-09-08 Kombination von Phenylcarbonsäureamiden mit beta-Adrenozeptoren-Blockern und deren Verwendung zur Behandlung von Vorhofarrhythmien
DE10341233.6 2003-09-08
PCT/EP2004/009837 WO2005025674A1 (fr) 2003-09-08 2004-09-03 Combinaison d'amides de l'acide phenylcarboxylique avec des bloquants des recepteurs beta-adrenergiques et leur utilisation dans le traitement d'arythmies atriales

Publications (1)

Publication Number Publication Date
CA2538009A1 true CA2538009A1 (fr) 2005-03-24

Family

ID=34202398

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002538009A Abandoned CA2538009A1 (fr) 2003-09-08 2004-09-03 Combinaison d'amides de l'acide phenylcarboxylique avec des bloquants des recepteurs beta-adrenergiques et leur utilisation dans le traitement d'arythmies atriales

Country Status (12)

Country Link
EP (1) EP1670551A1 (fr)
JP (1) JP2007505036A (fr)
AR (1) AR045601A1 (fr)
AU (1) AU2004271697A1 (fr)
BR (1) BRPI0414203A (fr)
CA (1) CA2538009A1 (fr)
DE (1) DE10341233A1 (fr)
IL (1) IL173919A0 (fr)
MX (1) MXPA06002103A (fr)
PE (1) PE20050373A1 (fr)
TW (1) TW200526580A (fr)
WO (1) WO2005025674A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005028862A1 (de) * 2005-06-22 2007-01-11 Sanofi-Aventis Deutschland Gmbh Substituierte Heterocyclen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
TW200812962A (en) * 2006-07-12 2008-03-16 Astrazeneca Ab New compounds I/418
MX2011012712A (es) 2009-05-29 2012-01-30 Raqualia Pharma Inc Derivados de carboxamida sustituidos con arilo como bloqueadores del canal de calcio o sodio.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194458B1 (en) * 1998-10-30 2001-02-27 Merck & Co., Inc. Benzamide potassium channel inhibitors
DE19947457A1 (de) * 1999-10-02 2001-04-05 Aventis Pharma Gmbh 2'-Substituierte 1,1'-Biphenyl-2-carbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
DE10059418A1 (de) * 2000-11-30 2002-06-20 Aventis Pharma Gmbh Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10060807A1 (de) * 2000-12-07 2002-06-20 Aventis Pharma Gmbh Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10128331A1 (de) * 2001-06-12 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
BRPI0414203A (pt) 2006-10-31
AU2004271697A1 (en) 2005-03-24
TW200526580A (en) 2005-08-16
JP2007505036A (ja) 2007-03-08
DE10341233A1 (de) 2005-03-24
WO2005025674A1 (fr) 2005-03-24
IL173919A0 (en) 2006-07-05
EP1670551A1 (fr) 2006-06-21
PE20050373A1 (es) 2005-07-05
MXPA06002103A (es) 2006-05-31
AR045601A1 (es) 2005-11-02

Similar Documents

Publication Publication Date Title
JP4231295B2 (ja) アントラニル酸アミド、その製造方法、抗不整脈剤としてのその使用、およびその医薬調製物
RU2275360C2 (ru) Ортозамещенные азотсодержащие бисарильные соединения для применения в качестве ингибиторов калиевого канала, а также содержащие их фармацевтические композиции
KR100863924B1 (ko) 헤테로아릴설포닐 측쇄를 갖는 안트라닐산 아미드 및 당해 화합물을 함유하는 약제학적 제제
AU2007245891B2 (en) Inhibitors of the TASK-1 and TASK-3 ion channel
CZ301631B6 (cs) Ortho- a meta-substituované bisarylové slouceniny a farmaceutické prostredky, které je obsahují
JP2022527916A (ja) アンドロゲン受容体のｎ末端ドメインの阻害剤
US20050054673A1 (en) Combination of phenylcarboxylic acid amides with beta-adrenoreceptor blockers and their use for the treatment of atrial arrhythmias
ZA200506328B (en) 2-(butyl-1sylfonylamino)-N-Ä1(R)-6methoxy-pyridin-3-yl)-propylÜ-benzamid, the use thereof in the form of drug an pharmaceutical preperations containing said compound
US20070043091A1 (en) Kv1.5-BLOCKER FOR THE SELECTIVE INCREASE OF ATRIAL CONTRACTILITY AND TREATMENT OF CARDIAC INSUFFICIENCY
CA2538009A1 (fr) Combinaison d'amides de l'acide phenylcarboxylique avec des bloquants des recepteurs beta-adrenergiques et leur utilisation dans le traitement d'arythmies atriales
US8106099B2 (en) Combination of phenylcarboxamides with blockers of the IKr channel and their use for the treatment of atrial arrhythmias
CA2519002A1 (fr) Association d'amides de l'acide phenylcarboxylique et d'inhibiteurs du canal ik<sb>r</sb> et utilisation de cette association pour traiter des arythmies atriales
US20080081926A1 (en) Sulfonylaminobenzoic acid and salt
CN101778828A (zh) 唑基亚甲基肼衍生物及其用途
MXPA06008926A (en) Kv1.5-blocker for the selective increase of atrial contractility and treatment of cardiac insufficiency

Legal Events

Date Code Title Description
FZDE Discontinued